Vladimir Rafalskiy

1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL

Ira M. Jacobson, G.J. Dore, Graham R. Foster et al. · Journal of Hepatology · 2013 · 89 citations · Full text

Hepatitis C, Viral Hepatitis, Immunodeficiencies +8

Distribution and antibiotic resistance profile of key Gram-negative bacteria that cause community-onset urinary tract infections in the Russian Federation: RESOURCE multicentre surveillance 2017 study

Vladimir Rafalskiy, S. V. Yakovlev, O. I. Epstein et al. · Journal of Global Antimicrobial Resistance · 2019 · 42 citations · Full text

Assessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2)

Marina Kalashnikova, D. Yu. Belousov, Vladimir Rafalskiy et al. · Diabetes Mellitus · 2016 · 29 citations · Full text

Russian Federation, рHarmacoepidemiological Study, Metabolic Syndrome +17

Surface-enhanced Raman spectroscopy for antiplatelet therapy effectiveness assessment

Andrey Zyubin, Vladimir Rafalskiy, Anna V. Tcibulnikova et al. · Laser Physics Letters · 2020 · 26 citations

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)

Marina Kalashnikova, D. Yu. Belousov, Vladimir Rafalskiy et al. · Diabetes Mellitus · 2018 · 23 citations · Full text

Total Cost, Russian Federation, Health Care Finance +17